Vyvanse can stop working effectively for several reasons, from tolerance buildup and sleep deprivation to a dose that no longer matches your needs. The medication has a unique activation process that depends on enzymes inside your red blood cells, and anything that disrupts the chain from ingestion to brain effect can blunt its impact. Understanding what’s changed can help you figure out the right next step.
How Vyvanse Works (and Where It Can Stall)
Vyvanse isn’t active when you swallow it. It’s a prodrug, meaning your body has to convert it into its active form, dextroamphetamine, before it does anything. That conversion happens inside your red blood cells, where specific enzymes strip away the amino acid lysine attached to the drug molecule. This process is the rate-limiting step: it controls how quickly the medication enters your system and is the reason Vyvanse has a smoother onset than immediate-release stimulants.
Once converted, dextroamphetamine reaches peak blood levels about 3 to 4.7 hours after you take the capsule, and therapeutic effects typically last 13 to 14 hours. Because the drug depends on enzymatic conversion rather than a slow-release coating, stomach acid and gut pH have almost no effect on its absorption. This means common suspects like antacids, coffee acidity, or food in your stomach are unlikely to meaningfully change how much active medication reaches your brain.
Tolerance Is the Most Common Culprit
If Vyvanse worked well at first and has gradually become less effective, pharmacodynamic tolerance is the most likely explanation. Your brain adapts to the consistent presence of a stimulant by making changes at the receptor level. Specifically, the dopamine transporter, the protein that Vyvanse blocks to keep dopamine active in the synapse, can increase in number by roughly 24% over a year of treatment. More transporters means dopamine gets cleared faster, which weakens the medication’s effect.
Your brain can also become less sensitive at the receptors that detect dopamine in the first place. Animal studies show that chronic stimulant exposure leads to reduced dopamine release over time, likely from increased sensitivity of the autoreceptors that act as a “brake” on dopamine output. The result feels like the medication is doing less, even though you’re taking the same dose.
Interestingly, one long-term brain imaging study found that even though dopamine transporter levels increased significantly, patients still reported that their ADHD symptoms remained controlled throughout the year. The researchers speculated that the real consequence of transporter upregulation is worse symptoms during the hours when the medication has worn off, not necessarily during peak effect. If your main complaint is that evenings and mornings feel dramatically harder than they used to, this mechanism could be the reason.
Sleep Changes Everything
Sleep deprivation is one of the fastest ways to make Vyvanse feel useless. Stimulants work by increasing dopamine and norepinephrine signaling, but those systems are already depleted when you haven’t slept enough. Research on stimulant use in sleep-deprived populations consistently shows that the cognitive benefits of these medications are significantly reduced when sleep debt accumulates. A stimulant can push an alert brain into sharp focus. It struggles to compensate for a brain running on empty.
This creates a frustrating cycle for people with ADHD, since ADHD itself makes it harder to fall asleep and maintain a consistent schedule. If your sleep has worsened recently, whether from stress, late-night screen use, or the medication itself keeping you up, that alone can explain why Vyvanse feels like it stopped working. Addressing sleep often restores the medication’s effectiveness without any dose change.
Your Dose May Be Too Low
Vyvanse is typically started at 30 mg per day, with increases in small increments up to a maximum of 70 mg. If you’ve been on the same dose for a while and your symptoms have crept back, you may simply need an adjustment. This is especially true if you were started on a conservative dose and never fully optimized. Some people need the full 70 mg to reach adequate symptom control, and there’s nothing abnormal about that.
Dose optimization isn’t just about the number on the capsule. It also involves timing. If the medication wears off too early in the day, the issue isn’t that it’s “not working” but that its 13- to 14-hour window doesn’t align with when you need coverage most. Taking it earlier or discussing a short-acting booster for late afternoon with your prescriber can make a meaningful difference.
Hormonal Fluctuations in Women
If you menstruate and notice that Vyvanse seems to work well during some weeks but not others, hormones are a strong suspect. Stimulant response varies across the menstrual cycle in ways that are well documented but rarely discussed in clinical settings. During the luteal phase (the roughly two weeks before your period, when progesterone is high), the subjective effects of amphetamine are generally attenuated. Women in studies report feeling less benefit from the same dose during this phase compared to the follicular phase, when progesterone is low.
The relationship is complex. One study found that administering progesterone to women actually enhanced some of amphetamine’s subjective effects, which contradicted expectations based on animal research. The takeaway is that hormonal shifts genuinely alter how your brain responds to stimulants, and the pattern isn’t always predictable. Tracking your symptoms alongside your cycle for two to three months can reveal whether your “bad Vyvanse days” line up with specific hormonal phases. Some prescribers adjust dosing across the cycle or add support during the luteal phase.
Stress, Anxiety, and Competing Demands
Vyvanse treats the neurochemical component of ADHD, but ADHD symptoms also worsen under psychological load. A period of high stress, a new job, relationship difficulties, or untreated anxiety can all make it feel like your medication stopped working when the real issue is that the demands on your executive function have outpaced what the medication can compensate for. Stimulants improve the signal-to-noise ratio in your brain’s attention systems. They don’t eliminate the noise.
Anxiety deserves special attention here. Stimulants can sometimes worsen anxiety, and anxiety itself impairs focus and working memory in ways that look identical to undertreated ADHD. If you’ve become more anxious since starting or increasing Vyvanse, the medication may technically be “working” on dopamine while simultaneously creating a new problem that cancels out the benefit.
Generic Versions and Formulation Differences
If you recently switched from brand-name Vyvanse to a generic lisdexamfetamine, you might wonder whether the formulation is the problem. Bioequivalence testing of generic versions shows that the active dextroamphetamine produced in the body is nearly identical to the brand, with blood concentration ratios around 99% for peak levels and 98% for total exposure. The prodrug itself showed slightly more variation, but since the prodrug is inactive, what matters is how much dextroamphetamine your body actually makes from it. Based on available data, switching to a generic is unlikely to explain a noticeable drop in effectiveness.
What a Medication Review Looks Like
Clinical guidelines recommend reviewing ADHD medication at least once a year to assess whether the current approach is still optimal. That review should cover whether dose optimization has actually been achieved, whether remaining symptoms might stem from a coexisting condition like anxiety or depression rather than ADHD itself, and whether side effects are creating problems that offset the benefits.
For some people, a structured break from medication (sometimes called a drug holiday) can help clarify whether the drug is still providing benefit. Evidence supports that symptoms typically worsen during these breaks, which, counterintuitively, can be useful information: it confirms the medication was doing something, even if the effect felt subtle. These breaks can also reduce side effects and, in theory, allow some degree of receptor resensitization, though the evidence for a full “tolerance reset” is limited. Whether a break makes sense depends entirely on your individual situation and should be a collaborative decision with your prescriber.
If you’ve been on the same dose for months and feel like you’re back to square one, the most productive step is a systematic review: assess your sleep, track your cycle if applicable, note when in the day symptoms are worst, and bring that information to your next appointment. The answer is rarely that Vyvanse has simply “stopped working.” More often, something in the equation has shifted, and identifying what changed points directly to the fix.